Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps

Spinal muscular atrophy (SMA) is a recessive disorder caused by a mutation in the survival motor neuron 1 gene (SMN1); it affects 1 in 11 000 newborn infants. The most severe and most common form, type 1 SMA, is associated with early mortality in most cases and severe disability in survivors. Nusine...

ver descrição completa

Detalhes bibliográficos
Main Authors: Gidaro, T, Servais, L
Formato: Journal article
Idioma:English
Publicado em: Wiley 2018